Clinical Trials Browser

Phase NA × INDUSTRY × Multiple Myeloma × Clear all

NCT05587972 2026-02-23

Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring

Phase NA Active not recruiting

BreastGastrointestinalPlasma cellThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Multiple Myeloma

NCT07100067 2025-12-29

LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma

Phase NA Recruiting

Multiple Myeloma

NCT07248176 2025-12-01

Universal CAR-T Cell Therapy for MM

Phase NA Recruiting

Multiple Myeloma

NCT05618041 2025-06-24

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

Phase NA Recruiting

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05956457 2025-04-20

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Phase NA Recruiting

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

NCT05053607 2024-12-11

Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab

Phase NA Recruiting

Multiple Myeloma

NCT02911571 2024-12-03

PROMMIS

Phase NA Active not recruiting

Multiple Myeloma

NCT05260203 2024-11-06

MargheRITA

Phase NA Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT05064787 2024-05-24

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

Phase NA Completed

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05308875 2024-01-05

Efficacy and Safety Evaluation of PD1-BCMA-CART

Phase NA Unknown

Multiple Myeloma

NCT05619861 2022-11-17

CAR-T Cells in the Treatment of Malignant Hematological Tumors

Phase NA Unknown

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, B-Cell, Leukemia, T-Cell, Lymphoma, B-Cell

NCT03752541 2022-05-20

Efficacy and Safety Evaluation of BCMA-UCART

Phase NA Suspended

Multiple Myeloma

NCT03492268 2022-05-17

Safety and Efficacy Evaluation of BCMA-CART for Treating Multiple Myeloma

Phase NA Withdrawn

Multiple Myeloma

NCT04447573 2020-09-29

Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase NA Unknown

Multiple Myeloma

NCT00656305 2020-02-05

ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain

Phase NA Completed

147 enrolled 12 charts

BreastGenitourinaryPlasma cellSarcomaThoracic

Cancer Pain, Bone Neoplasms, Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT03046329 2019-11-07

Improving the Quality of Multiple Myeloma Treatment With Patient Care Plans

Phase NA Completed

Multiple Myeloma

NCT01423760 2016-10-06

Common Safety Follow-up Trial of Tecemotide (L-BLP25)

Phase NA Terminated

27 enrolled 7 charts

Plasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Multiple Myeloma

NCT01292486 2013-05-01

Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure

Phase NA Completed

32 enrolled 11 charts

Multiple Myeloma

NCT01572688 2012-08-02

MM

Phase NA Unknown

Multiple Myeloma